| Literature DB >> 22471612 |
Navid Adnani1, Cole R Michel, Tim S Bugni.
Abstract
A lack of good methods for absolute quantification of natural products has limited the accuracy of high-throughput screening. Many currently used methods for quantification are either too slow or not amenable to the structural diversity of natural products. Recent developments in low-temperature evaporative light scattering detectors (ELSD-LT) have overcome several historical limitations of ELSDs, including analyte decomposition and low sensitivity. Primarily, ELSDs have been used for relative quantification and detection of compounds that lack a UV chromophore. In this study, we employ an ELSD-LT for absolute quantification of natural products. Calibration curves were constructed using a weighted least-squares analysis for a diverse set of natural products and other compounds. An average calibration curve was evaluated for the "universal" quantification of natural products. Optimization of ELSD-LT hardware and parameters improved sensitivity and throughput and established the utility of ELSD-LT for quantification of large natural product libraries.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22471612 PMCID: PMC3338159 DOI: 10.1021/np300034c
Source DB: PubMed Journal: J Nat Prod ISSN: 0163-3864 Impact factor: 4.050
Compounds Used as Standards for Quantification Using an ELSD
| name | molecular weight (g/mol) |
|---|---|
| apigenin | 270.24 |
| phloretin | 274.27 |
| cycloheximide | 281.35 |
| hematoxylin | 302.28 |
| tamoxifen | 371.51 |
| ochratoxin A | 403.81 |
| pepstatin A | 685.89 |
| rifampicin | 822.94 |
| paclitaxel | 853.91 |
| cyclosporin A | 1202.61 |
Figure 1Effects of solvent composition and evaporation temperature on ELSD response.
Figure 2Calibration curve of cycloheximide.
Calibration Curve Data for Each of the 10 Standards and the Average Calibration Curve
| compound | LOQ (ng) | slope | |
|---|---|---|---|
| apigenin | 15.6 | 1.38 | 2.60 |
| phloretin | 7.81 | 1.49 | 2.16 |
| cycloheximide | 15.6 | 1.31 | 2.49 |
| hematoxylin | 15.6 | 1.38 | 2.18 |
| tamoxifen | 7.81 | 1.42 | 2.46 |
| ochratoxin A | 15.6 | 1.34 | 2.22 |
| pepstatin A | 31.3 | 1.40 | 2.23 |
| rifampicin | 7.81 | 1.29 | 2.44 |
| paclitaxel | 15.6 | 1.56 | 1.90 |
| cyclosporine A | 15.6 | 1.22 | 2.83 |
| average | 1.49 | 2.70 |
Figure 3Comparison of standard calibration curves and construction of average “universal” calibration curve.
Average Error (%) Associated with Quantifications of All 10 Standards for Each Amount Injected using the “Universal” Calibration Curve
| quantity (ng) | positive error (%) | negative error (%) |
|---|---|---|
| 500 | 27.1 | –21.3 |
| 250 | 31.0 | –23.7 |
| 125 | 31.9 | –23.6 |
| 62.5 | 29.0 | –22.5 |
| 31.3 | 31.3 | –23.8 |
Error Associated with Pure Samples Versus Mixtures
| mixture | experimentaly determined (ng) | error (%) |
|---|---|---|
| rifampicin | 238 | 4.8 |
| rifampicin:cycloheximide (3:1) | 231 | 7.6 |
| rifampicin:cycloheximide (1:1) | 230 | 8.0 |
| rifampicin:cycloheximide (1:3) | 243 | 2.8 |
| cycloheximide | 251 | 0.4 |
| ochratoxin A | 202 | 19.2 |
| ochratoxin A:apigenin (3:1) | 239 | 4.4 |
| ochratoxin A:apigenin (1:1) | 295 | 18.0 |
| ochratoxin A:apigenin (1:3) | 354 | 41.6 |
| apigenin | 383 | 53.2 |
For each sample a total of 250 ng was analyzed. The experimental quantification was performed using the “universal” calibration curve.